PF-07062119
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-07062119, covering 2025-01-16 to 2025-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors. [Phase 1]